Glucosamine in osteoarthritis and gastrointestinal disorders: An exemplar of the need for a paradigm shift

Medical Hypotheses

Volumn 51, Issue 4, 1998, Pages 347-349

  Russell, A L ^a  

^a Brampton Pain Clinic   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSAMINE; GLUCOSE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEOGLYCAN;

ATHLETE; CARTILAGE; GASTROINTESTINAL DISEASE; HUMAN; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; WOUND HEALING;

EID: 0031788524     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90060-3     Document Type: Article

References (8)

1. McCarty M F. The neglect of glucosamine as a treatment for osteoarthritis - a personal perspective. Med Hypotheses 1994; 42: 323-327.
2. Russell A L. Piroxicam 0.5% topical gel compared to placebo in the treatment of acute soft tissue injuries: a double-blind study comparing efficacy and safety. Clin Invest Med 1993; 14: 35-43
3. Russell A L. Review and evaluation of 3% diclofenac in hyaluronan DHA gel. Royal Society of Medicine Series, No. 33; 1994: 64-69.
4. Russell A L. The use of HYAL AT-2101 and diclofenac in the treatment of osteoarthritis. Royal Society of Medicine Series, No. 36; 1995: 58-65.
5. McCarty M F. Glucosamine for wound healing. Med Hypotheses 1996; 47: 273-275.
6. Prudden J F. Method and Agent for Treating Inflammatory Disorders of the Gastrointestinal Tract. United States Patent # 4,006,224, 1977.
7. Burton A F, Freeman H J. Method for Treatment of Lower Gastrointestinal Tract Disorders. United States Patent # 5,229,374, 1993.
8. Laurent T C. The biology of hyaluronan. Ciba Foundation Symposium 143. Wiley, New York: 1989.